Shanghai and Shenzhen stock exchanges:
Hongsheng Huayuan (**601096).
On December 22, Hongsheng Huayuan landed on the main board of the Shanghai Stock Exchange. The company's main business is the R&D, production and sales of transmission line towers, and the main products are a full range of transmission line towers of voltage levels, including angle steel towers, steel pipe towers, steel pipe poles, and substation structure supports. In addition, the company also produces a small number of steel structure products such as communication towers and steel components for construction machinery.
Fundraising:
In this IPO, Hongsheng Huayuan plans to issue **66.9 billion shares, accounting for 25% of the total share capital after the issuance, and the total share capital after the issuance is 267.5 billion shares. After deducting the issuance expenses, the net amount to be raised is 100 billion yuan, which is intended to be used for the production project of Hongsheng Huayuan Tower Group Co., Ltd. full range of voltage level transmission towers, Hongsheng Huayuan Tower Group Co., Ltd. intelligent manufacturing upgrading project and supplementary working capital project. The actual issuance of shares 66.9 billion shares at an issue price of 170 yuan shares, the actual net amount of funds raised is 103.7 billion yuan, higher than the net amount to be raised.
Specific stock price performance:
Issue Price: 170 yuan.
Opening price: 560 yuan.
The most**: 9$90.
Lowest: 5$27.
* Price: 749 yuan.
Change: +34059%
Turnover rate: 7482%
Company market capitalization: 2003.7 billion.
On December 22, Hongsheng Huayuan landed on the main board of the Shanghai Stock Exchange with an opening price of 560 yuan shares, compared with the issue price **22941%。
According to the prospectus, from 2020 to 2022 and from January to June 2023, Hongsheng Huayuan's operating income will be 61 respectively0.7 billion yuan, 716.2 billion yuan, 877.1 billion and 457.4 billion yuan, and the net profit attributable to the parent company was 52.2 billion yuan, 20.7 billion yuan, 16.6 billion and 06.9 billion yuan.
Hong Kong stocks:
OneJihai Resources (**02489) On December 22, Jihai Resources landed on the Hong Kong Stock Exchange. The company is a leading exploration, mining and processing company established in 2005 and located in Yantai City, Shandong Province, China. The company sells gold ingots made from gold concentrate processed in-house. According to the Frost & Sullivan report, the company is the third largest mining company in Shandong Province in 2022, with a market share of 26% (in terms of mine production), but in terms of mine production, the combined market share of the top two players is around 783% 。Fundraising:
In this IPO, Jihai Resources intends to offer 50 billion shares, including 50 million shares in the Hong Kong offer and 4 shares in the international offering5 billion shares, the offering ** is intended to be no more than 0. per shareHK$75, not less than 0HK$55, assuming an offer** of 0. per shareHK$65 (i.e. the median of the above offering** range), and the net proceeds of the Company (net of underwriting commissions and other estimated expenses payable in the Global Offering) are expected to be approximately 2HK$6.5 billion, with the proceeds intended to be used for further construction of mining infrastructure in line with the Mine Optimisation PlanUpgrading of ** ore reserves to increase mine life through additional exploration activities at the Company's existing tenements;Expansion of the Company's business through selective acquisition of gold mining assets;Repayment of existing bank loan guarantees;Working capital. The actual offering of shares 50 billion shares, the actual issue price is 0HK$55, and the net amount of funds actually raised was about 2HK$1.7 billion. Specific stock price performance:
Issue price: 0HK$55.
Opening Price: 0HK$51.
Most**: 0HK$58.
Lowest: 0HK$51.
*Price: 0HK$56.
Change: +182%
Turnover rate: 556%
Value: 112 billion.
On December 22, Jihai Resources landed on the Hong Kong Stock Exchange. It became the first private mining company in Shandong Province to be listed in Hong Kong. According to the prospectus, in 2020, 2021, 2022 and the first half of 2023, Jihai Resources will achieve revenue of about 36.1 billion yuan, 24.8 billion and 41.8 billion yuan, 19.7 billion yuan, and the net profit attributable to the parent company was about 08.2 billion yuan, 04.2 billion yuan, 08.3 billion yuan, 03.7 billion yuan. IIHighTide Pharmaceutical-B (**02511) On December 22, HighTide Pharmaceutical-B landed on the Hong Kong Stock Exchange. The Company is a biopharmaceutical company focused on the discovery, development and commercialization of multifunctional and multi-target targets for metabolic and digestive diseases. The company's core product, HTD1801 (berberine ursodeoxycholate), is a novel molecular entity that acts as an intestinal and hepatic anti-inflammatory and metabolic regulator, targeting multiple pathways that are critical to the body's metabolic processes, including those related to metabolic and digestive diseases. Fundraising:
In this IPO, HighTide Pharmaceutical-B plans to offer 2419 shares400,000 shares, of which 241 are offered in Hong Kong950,000 shares, 2,177 shares in the international offering450,000 shares, offering ** at 11. per shareHK$50, and the net proceeds of the Company (net of underwriting commissions and other estimated expenses payable on the Global Offering) are expected to be approximately 1HK$9.4 billion, with the proceeds intended to be used to fund ongoing clinical research and development activities for the core product HTD1801;Used to fund the ongoing research and development of HTD1804 in obesity;Used to continuously upgrade and enhance FusionTX;For working capital and other general corporate purposes. The actual offering of shares is 2419400,000 shares, the actual issue price is 11HK$50, and the net amount of funds actually raised is about 1HK$9.4 billion. Specific stock price performance:
Issue price: 11HK$50.
Opening price: 11HK$92.
The most**:12HK$68.
Low: 11HK$92.
* Price: 12HK$38.
Change: +765%
Turnover rate: 099%
Value: 637.3 billion.
On December 22, HighTide Pharma-B landed on the Hong Kong Stock Exchange. The IPO took only 6 days from the submission of the form on December 4 to the hearing on December 10. According to the prospectus, in 2021, 2022 and the first half of 2023, HighTide Pharmaceutical's loss will reach 21.7 billion yuan, 22.4 billion yuan, 58.6 billion yuan;R&D investment was 08.4 billion yuan, 18.3 billion yuan, 1$2 billion, accounting for % of the total operating expenses for the same period;Among them, the R&D cost of the core product HTD1801 accounted for the total R&D expenditure1% and 952%。
IIIFanyuan International (**02516) On December 22, Fanyuan International landed on the Hong Kong Stock Exchange. Headquartered in China, the company is a leading provider of cross-border e-commerce logistics services, mainly engaged in providing end-to-end cross-border logistics services. Fundraising:
In this IPO, Fanyuan International intends to offer 14 billion shares, including 14 million shares for public offering and 1 for placing shares2.6 billion shares, the offering ** is intended to be no more than 1. per shareHK$22, not less than HK$0HK$90, assuming an offer** of 1. per shareHK$06 (i.e. the median of the above offering** range), the net proceeds of the company (net of underwriting commissions and other estimated expenses payable in the global offering) are expected to be approximately HK$88.5 million, and the funds raised are intended to be used to achieve greater scale and production capacity and expand business areas;Invest in and upgrade the company's IT systems;Working capital and general corporate purposes. The actual offering of shares 14 billion shares, the actual issue price is 0. per shareHK$90, and the net amount of funds actually raised was about HK$66.89 million. Specific stock price performance:
Issue price: 0HK$90.
Opening price: 1HK$30.
The most**:132 ports.
Lowest: 0HK$91.
* Price: 1HK$00.
Change: +1111%
Turnover rate: 476%
Value: 78 billion.
On December 22, Fanyuan International landed on the Hong Kong Stock Exchange. Opening price: 1HK$30, compared with the issue price **444%。According to the prospectus, in 2020, 2021, 2022 and the first six months of 2023, the operating income of Fanyuan International Logistics will be 151.2 billion, 135.4 billion, 125.2 billion and 67.4 billion yuan, and the corresponding net profit was 526950,000, 368920,000, 30089 and 117440,000 yuan. FourthLancang Ancient Tea (**06911) On December 22, Lancang Ancient Tea landed on the Hong Kong Stock Exchange. According to the Frost & Sullivan Report, the Company is the third largest Pu-erh tea company in China in terms of revenue generated by Pu'er tea products in 2022. Fundraising:
In this IPO, Lancang Ancient Tea intends to offer 21 million shares globally, including 2.1 million shares in Hong Kong and 18.9 million shares in the international offering, and the offering ** is not higher than 14 per shareHK$16, not less than HK$10HK$40, assuming an offer** of HK$12 per shareHK$28 (i.e. the median of the above offering** range), and the net proceeds of the Company (net of underwriting commissions and other estimated expenses payable in the Global Offering) are expected to be approximately 1HK$85.9 billion, the funds raised are intended to be used to establish a modern logistics and warehousing center, build a new production workshop and improve the existing production plant;Build a sales pipeline;Brand building and product marketing;Strategic investment and acquisition opportunities in the tea industry;upgrading IT infrastructure and strengthening R&D capabilities;Working capital and other general corporate purposes. The actual offering of shares is 21 million shares, and the actual issue price is 10 per share70 Hong Kong dollars, the actual net amount of funds raised is about 1HK$59.9 billion. Specific stock price performance:
Issue price: 10HK$70.
Opening price: 10HK$70.
The most**:1194 Port.
Low: 8HK$70.
* Price: 8HK$70.
Change rate: -1869%
Turnover rate: 987%
Harbor ** Value: 18.3 billion.
On December 22, Lancang Ancient Tea, the "first share of Pu'er tea", landed on the Hong Kong Stock Exchange. The company submitted a listing application to the Shenzhen Stock Exchange in 2020, and later announced that it had withdrawn the application materials. In 2022, Lancang Ancient Tea will be "diverted" to the Hong Kong Stock Exchange. In August 2023, Lancang Ancient Tea submitted its form to the Hong Kong Stock Exchange for the third time, and now it has finally been successfully listed. According to the prospectus, in 2020, 2021, and 2022, the company's earnings will be 40.5 billion yuan, 55.9 billion yuan, 46.3 billion yuan;During the same period, the company's gross profit was6.8 billion yuan, 30.5 billion yuan;The gross profit margins were ., respectively9%；The net profit was 12.3 billion yuan, 12.9 billion yuan, 070.5 billion yuan.